DUBLIN, April 13, 2022 /PRNewswire/ — The “Antibiotic Resistance Marketplaces – Therapeutics by Pathogen and Treatment Type. With Problem Evaluation, Government & Investor Guides & Customization.” report has been added to ResearchAndMarkets.com’s supplying.
The report has determined 6 Important Substantial Options in this room and developed marketplace forecasts.
Antimicrobial Resistance is building new varieties of infections and “superbugs” that are resistant to latest antibiotic medications. New technologies (and new medicines) are beneath progress to capture this expanding market place.
The report has seemed at the technological know-how photo way too, supplying you, simple language comprehending of the distinct means pathogens, and bacterial infections, can be addressed, such as an clarification of the important part diagnostics will participate in. This is a market place with a lot of players, there are more than 100 biotechnology corporations profiled in the report. The report summarizes what technologies they are applying.
Make expenditure conclusions and valuations with confidence applying the most up-to-date facts. The report involves 5-calendar year industry forecasts.
Essential Topics Lined:
Overview of a Dynamic Industry
Sector Gamers – Roles & Impacts
- Drug producers – More substantial/pharmaceutical
- Drug companies – Generic
- Contract Research and Manufacturing
- In Vitro Diagnostics Business
- Drug Internet marketing Companies
- Biotechnology Providers
- Regulatory Bodies
Knowing Antimicrobial Resistance
- What is Antimicrobial Resistance (AMR)
- Germs and Other Microbes
- The History of Antibiotics
- The Function of Animal Husbandry
- The Implications of Horizontal Transfer
- The Risk of AMR
The Modifying Road to New Antibiotics & Technologies
The Key Job of Diagnostics in AMR
The Market place Possibility of AMR
The Key Huge Current market Options in AMR
- Streptococcus Pneumoniae (DRSP)
- Campylobacter (DRC)
- Clostridium Difficile (CD)
- Staphylococcus aureus (MRSA)
- Neisseria gonorrhoeae (DRNG)
- Salmonella (DRNTS)
Therapeutic Technologies Advancement Options
- Employing Viruses Versus Microorganisms
- Hydrolytic Enzymes Join the Fight
- Probiotic Know-how
- Peptides vs. Pathogens
- Mining Out of date Science
- CRISPR Antibiotics
Antibiotic Resistance Current Developments
- AMR Pandemic Ignored
- New resistance-busting antibiotic blend
- CDC Awards $22M to Combat Antimicrobial Resistance
- Antibiotic resistance outwitted by supercomputers
- STIs Access History Highs
- New exploration using nanoparticles to bolster waning antibiotics
- OpGen Receives Fda Clearance for AMR Panel
- CDC Updates STI Diagnosis, Cure Recommendations
- Positive associations concerning AM use in animals and AMR in people
- PEW Antibiotic Pipeline Findings
Vital Biotechnology Companies and Their Engineering
- Melinta Therapeutics
- Phage Technologies S.A
- Westway Health and fitness
- Tetraphase Prescription drugs
- BioVersys GmbH
- Nabriva Therapeutics
- Macrolide Prescribed drugs
- Nemesis Bioscience
- C3J Therapeutics, Inc.
- AmpliPhi Biosciences
- Pherecydes Pharma
- Procarta Biosystems
- Madam Therapeutics
- Biolytx Pharmaceuticals
- Xellia Pharmaceutials
- Paratek Pharmaceuticals
- Synereca Pharmaceuticals
- Allecra Therapeutics
- Fastened Phage
- Enanta Pharmaceuticals, Inc.
- Innovation Prescription drugs
- Aviragen Therapeutics
- Achillion Pharmaceuticals
- ImmunNovative Developments, S.L.
- Achaogen, Inc.
- SelectX Prescription drugs, Inc.
- TaiGen Biotechnology Co., Ltd.
- Theravance Biopharma
- KYORIN Pharmaceutical Co.,Ltd.
- Iterum Therapeutics Limited
- Forge Therapeutics
- Alopexx Vaccine LLC
- Integrated Biotherapeutics
- Hennepin Lifestyle Sciences
- Fedora Prescription drugs Inc.
- Contrafect Company
- Basilea Pharmaceutica Ltd.
- RedHill Biopharma
- Redx Pharma Plc/ Redx Anti Infectives Ltd.
- ABAC Therapeutics
- Alaxia SAS
- Antabio S.A.S
- Auspherix Ltd
- BioFilm Pharma
- Centauri Therapeutics Ltd
- Combioxin SA
- Da Volterra
- Debiopharm Intercontinental SA
- Destiny Pharma plc
- Eligo Bioscience
- Helperby Therapeutics Ltd
- Karveel Prescription drugs
- MaaT Pharma
- Motif BioSciences, Inc / Motif Bio PLC
- Mutabilis SAS
- Neem Biotech Ltd
- Northern Antibiotics Oy (Ltd)
- NovaBiotics Ltd
- Phico Therapeutics Ltd
- Polyphor Ltd
- QureTech Bio AB
- SetLance srl
- Ultupharma AB
- KBP Biosciences
- Absynth Biologics
- Spero Therapeutics
- Warp Push Bio.
- Johnson & Johnson (Janssen)
- Gilead Sciences
- Shionogi Inc.
- DSM Sinochem Pharmaceuticals
- Wockhardt Ltd.
- VenatoRx Pharmaceuticals
- Entasis Therapeutics
- Merlion Prescription drugs
- Aridis Prescribed drugs Inc.
For more facts about this report pay a visit to https://www.researchandmarkets.com/r/ohqqvk
Media Get in touch with:
Investigate and Markets
Laura Wooden, Senior Supervisor
For E.S.T Office environment Several hours Simply call +1-917-300-0470
For U.S./CAN Toll No cost Phone +1-800-526-8630
For GMT Business office Hrs Phone +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Supply Exploration and Markets